THE CYTOTOXICAL PROPERTIES OF OLEANANE ALDEHYDE-Β-ENONE AGAINST DOXORUBICIN-RESISTANT CANCER CELLS Daria V. Eroshenko, Irina A. Tolmacheva, Mikhail A. Nazarov, and Victoria V. Grishko Institute of Technical Chemistry of the Ural Branch of the Russian Academy of Sciences, Perm Federal Scientific Centre, Russia, 614013, Perm, Academician Koroleva st, 3 This study was aimed at assessing the proapoptotic potential of previously
synthesized oleanane aldehyde-β-enone (
OA ) [1] against cancer cell lines, including
doxorubin-resistant subclones with the P-gp overexpression.
OA showed equal toxicity
to parental HBL-100 and K562 cancer cells (IC
50
0.47–0.53 µM) and their Dox-resistant
subclones HBL-100/Dox, K562/i-S9 and K562/i-S9_Dox (IC
50
0.45−1.24 µM), as was
determined by the MTT test [2].
OA overcomes the resistance of overexpressing P-gp
cancer cells, with
OA being neither a direct inhibitor, nor a competitive substrate of P-
gp [2].
The
OA proapoptotic effect against HBL-100 and HBL-100/Dox cells was assessed
by means of double staining with the Annexin V/PI kit and analyzed by flow cytometry
after
OA treatment at IC
50
for 16 h. The
OA -treatment led to an increase in the early
and late apoptotic cell population for HBL-100 cells (23.6% vs 2.51% for untreated
cells) and HBL-100/Dox cells (8.06% vs 2.53% for untreated cells). In addition, the cell
cycle analysis of the HBL-100 and HBL-100/Dox cultures after 16 h
OA -treatment
evinced
OA to cause a significant increase (up to 9%) in the sub-G0/G1 subpopulation
with DNA-reduced cells. Fluorescence microscopy revealed the incubation of HBL-100
and HBL-100/Dox cells with of
OA to be accompanied by a significant decrease in
mitochondrial fluorescence (ΔΨm loss) and ROS generation. The release of cytochrome
c from mitochondria to cytosol in the HBL-100 and HBL-100/Dox cells, which was
more remarkable in HBL-100/Dox cells, was observed after 16 h